Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 4 | 5 |
| List of Tables | 7 | 1 |
| List of Figures | 8 | 1 |
| Introduction | 9 | 1 |
| GBI Research Report Guidance | 9 | 1 |
| PE/VC Deals Summary in the Medical Device Industry | 10 | 7 |
| PE/VC Deals by Number and Deal Value, 2007 2010 | 10 | 1 |
| Segmentation of PE/VC Deals by Stages, 2007 2010 | 11 | 1 |
| Conclusion | 12 | 1 |
| Withdrawn/Terminated Deals | 12 | 1 |
| Ion Beam Applications Terminated Sale of Its BioAssays Unit | 13 | 1 |
| Deal Rationale | 13 | 1 |
| Company Profile | 13 | 1 |
| Smiths Group Rejects Cash Bid of Apax Partners for Smiths Medical | 13 | 1 |
| Deal Rationale | 13 | 1 |
| Company Profile | 13 | 1 |
| Ares Life Sciences, Essex, Intesa and Alpha Terminated Acquisition of Sorin | 14 | 1 |
| Deal Rationale | 14 | 1 |
| Company Profile | 14 | 1 |
| AMICAS Terminated Acquisition with Thoma Bravo | 14 | 1 |
| Deal Rationale | 14 | 1 |
| Company Profile | 15 | 1 |
| Q-Med Terminated Offer for Its Acquisition by Ivytan | 15 | 1 |
| Deal Rationale | 15 | 1 |
| Company Profile | 15 | 1 |
| Endologix Terminated Offer for Its Acquisition by Elliot Associates | 15 | 1 |
| Deal Rationale | 15 | 1 |
| Company Profile | 16 | 1 |
| Conclusion | 16 | 1 |
| PE/VC Deals in Medical Devices by Geography | 17 | 6 |
| PE/VC Deals in North America | 17 | 2 |
| PE/VC Deals in Europe | 19 | 2 |
| PE/VC Deals in the Asia-Pacific | 21 | 1 |
| Conclusion | 22 | 1 |
| PE/VC Activity in Medical Devices by Market | 23 | 63 |
| In Vitro Diagnostics | 23 | 1 |
| Deals Analysis | 24 | 1 |
| PE/VC Deals - In Vitro Diagnostics | 24 | 1 |
| Pacific Biosciences Secured Additional $59m in Series F Round of Financing | 25 | 1 |
| Deal Rationale | 25 | 1 |
| Company Overview | 25 | 1 |
| Legal &General Ventures Sells LGC to Bridgepoint | 25 | 1 |
| Deal Rationale | 26 | 1 |
| Company Overview | 26 | 1 |
| Welsh, Carson, Anderson &Stowe Acquired Spectrum Laboratory Network from Apax Partners | 26 | 1 |
| Deal Rationale | 26 | 1 |
| Company Overview | 26 | 1 |
| Bridgepoint Capital Acquired Terveystalo Healthcare | 27 | 1 |
| Deal Rationale | 27 | 1 |
| Duke Street Acquired Biomnis | 27 | 1 |
| Deal Rationale | 27 | 1 |
| Company Overview | 27 | 1 |
| The EQT V fund Acquired Dako Denmark | 28 | 1 |
| Deal Rationale | 28 | 1 |
| Company Overview | 28 | 1 |
| Cardiovascular Devices | 29 | 1 |
| Deal Analysis | 30 | 1 |
| Ares Life Sciences Acquired Stake in Esaote | 30 | 1 |
| Deal Rationale | 31 | 1 |
| Company Overview | 31 | 1 |
| Boston Scientific Sells Fluid Management and Venous Access Businesses To Avista Capital | 31 | 1 |
| Deal Rationale | 31 | 1 |
| Company Overview | 31 | 1 |
| Cardionet Secures $110m in Series E Financing | 32 | 1 |
| Deal Rationale | 32 | 1 |
| Company Overview | 32 | 1 |
| Orthopedic Devices | 33 | 1 |
| Deals Analysis | 34 | 2 |
| Small Bone Innovations Secured $108m in Series D Financing | 36 | 1 |
| Deal Rationale | 36 | 1 |
| Company Overview | 36 | 1 |
| Globus Medical Secures $110m Series E Financing | 36 | 1 |
| Deal Rationale | 36 | 1 |
| Company Overview | 37 | 1 |
| Anesthesia and Respiratory Devices | 38 | 1 |
| Deals Analysis | 39 | 1 |
| Water Street Healthcare Acquires Stake in CareCentrix from Gentiva Health | 39 | 1 |
| Deal Rationale | 39 | 1 |
| Company Overview | 39 | 1 |
| Dental Devices | 40 | 1 |
| Deals Analysis | 41 | 1 |
| TA Associates Acquired Stake in Amann Girrbach | 41 | 1 |
| Deal Rationale | 41 | 1 |
| Company Overview | 41 | 1 |
| Palamon Capital Partners Completes Acquisition of Associated Dental Partners | 42 | 1 |
| Deal Rationale | 42 | 1 |
| Company Overview | 42 | 1 |
| Diabetes Care Devices | 43 | 1 |
| Deals Analysis | 44 | 1 |
| The Blackstone Group Acquires Apria Healthcare | 44 | 1 |
| Deal Rationale | 44 | 1 |
| Company Overview | 44 | 1 |
| Diagnostic Imaging | 45 | 1 |
| Deals Analysis | 46 | 1 |
| Bridgepoint Capital Acquired Terveystalo Healthcare | 46 | 1 |
| Deal Rationale | 47 | 1 |
| Company Overview | 47 | 1 |
| Merrill Lynch and Ares Acquires Euromedic from Warburg Pincus | 47 | 1 |
| Deal Rationale | 47 | 1 |
| Company Overview | 47 | 1 |
| Avista Capital Partners Acquired Bristol-Myers Squibb Medical Imaging | 48 | 1 |
| Deal Rationale | 48 | 1 |
| Company Overview | 48 | 1 |
| Dubai International Capital Acquired Alliance Medical from Bridgepoint Capital | 48 | 1 |
| Deal Rationale | 48 | 1 |
| Company Overview | 49 | 1 |
| DeA Capital and Mediobanca Acquired 53% Majority Stake in Generale de Sante | 49 | 1 |
| Deal Rationale | 49 | 1 |
| Company Overview | 49 | 1 |
| Drug Delivery Devices | 50 | 1 |
| Deals Analysis | 51 | 1 |
| Warburg Pincus Acquired Lifecore Biomedical | 51 | 1 |
| Deal Rationale | 51 | 1 |
| Company Overview | 51 | 1 |
| Endoscopy Devices | 52 | 1 |
| Deals Analysis | 53 | 1 |
| TPG Capital Acquires Axcan Pharma | 53 | 1 |
| Deal Rationale | 53 | 1 |
| Company Overview | 53 | 1 |
| Ear, Nose and Throat (ENT) Devices | 54 | 1 |
| Deals Analysis | 55 | 1 |
| Technitrol Sells Medtech Component Business To Altor | 55 | 1 |
| Deal Rationale | 55 | 1 |
| Company Overview | 55 | 1 |
| Healthcare IT | 56 | 2 |
| Huntsman Gay Global Acquires 51% Stake in Sunquest Information from Vista Equity Partners | 58 | 1 |
| Deal Rationale | 58 | 1 |
| Company Overview | 58 | 1 |
| BC Partners and Silver Lake Acquires MultiPlan from the Carlyle Group and Welsh, Carson, Anderson &Stowe | 58 | 1 |
| Deal Rationale | 58 | 1 |
| Company Overview | 58 | 1 |
| OMERS Private Equity Completes Acquisition of Logibec Groupe Informatique | 59 | 1 |
| Deal Rationale | 59 | 1 |
| Company Overview | 59 | 1 |
| Francisco Partners Completes Acquisition Of Quadramed | 60 | 1 |
| Deal Rationale | 60 | 1 |
| Company Overview | 60 | 1 |
| ikaSystems Received Additional Investment From Essex Woodlands Health | 61 | 1 |
| Deal Rationale | 61 | 1 |
| Company Overview | 61 | 1 |
| Truveris Raises $3.8m in First Venture Financing Round | 61 | 1 |
| Deal Rationale | 61 | 1 |
| Company Overview | 62 | 1 |
| Glocal Healthcare Systems to Raise $3.25m in Venture Financing | 62 | 1 |
| Deal Rationale | 62 | 1 |
| Company Overview | 62 | 1 |
| Apax Partners, Bluecross Blueshield and Regence Group Acquired the TriZetto Group | 62 | 1 |
| Deal rationale | 63 | 1 |
| Company Overview | 63 | 1 |
| Merrill Lynch and Ares Acquired Euromedic From Warburg Pincus | 63 | 1 |
| Deal Rationale | 63 | 1 |
| Company Overview | 63 | 1 |
| General Atlantic And Hellman &Friedman Acquires Remaining 48% Stake In Emdeon Business Services From HLTH | 64 | 1 |
| Deal Rationale | 64 | 1 |
| Company Overview | 64 | 1 |
| TA Associates Acquired Alere Medical | 64 | 1 |
| Deal Rationale | 65 | 1 |
| Company Overview | 65 | 1 |
| Hospital Supplies | 66 | 1 |
| Deals Analysis | 67 | 1 |
| The Blackstone Group Completes Acquisition of Polymer Group | 67 | 1 |
| Deal Rationale | 67 | 1 |
| Company Overview | 67 | 1 |
| EQT Partners Completed Acquisition of HTL-Strefa | 68 | 1 |
| Deal Rationale | 68 | 1 |
| Company Overview | 68 | 1 |
| Lehman Brothers Acquired Angelica | 68 | 1 |
| Deal Rationale | 68 | 1 |
| Company Overview | 69 | 1 |
| Tenet Healthcare Sells Its Majority Stake in Broadlane to TowerBrook Capital Partners | 69 | 1 |
| Deal Rationale | 69 | 1 |
| Company Overview | 69 | 1 |
| Nephrology and Urology Devices | 70 | 1 |
| Deals Analysis | 71 | 1 |
| Merrill Lynch and Ares Acquired Euromedic from Warburg Pincus | 71 | 1 |
| Deal Rationale | 71 | 1 |
| Company Overview | 71 | 1 |
| Neurology Devices | 72 | 1 |
| Deals Analysis | 73 | 1 |
| Ophthalmic Devices | 73 | 1 |
| 3i Acquired Ultralase from Corporacion Dermoestetica | 74 | 1 |
| Deal Rationale | 74 | 1 |
| Company Overview | 75 | 1 |
| Warburg Pincus Acquired Bausch &Lomb | 75 | 1 |
| Deal Rationale | 75 | 1 |
| Company Overview | 75 | 1 |
| Patient Monitoring | 76 | 1 |
| Deals Analysis | 77 | 1 |
| TA Associates Acquired Alere Medical | 77 | 1 |
| Deal Rationale | 77 | 1 |
| Company Overview | 77 | 1 |
| Surgical Equipment | 78 | 1 |
| Deals Analysis | 79 | 1 |
| PerkinElmer Sells Illumination and Detection Solutions Business to Veritas Capital Fund Management | 79 | 1 |
| Deal Rationale | 79 | 1 |
| Company Profile | 80 | 1 |
| HLTH Sells Porex to Aurora Capital | 80 | 1 |
| Deal Rationale | 80 | 1 |
| Company Overview | 80 | 1 |
| Wound Care Management | 81 | 1 |
| Deals Analysis | 82 | 1 |
| Investor Acquired 34% Stake in Molnlycke Health Care | 82 | 1 |
| Deal Rationale | 82 | 1 |
| Company Overview | 83 | 1 |
| Nordic Capital Fund and Avista Capital Partners Acquire ConvaTec from Bristol-Myers Squibb | 83 | 1 |
| Deal Rationale | 83 | 1 |
| Company Overview | 84 | 1 |
| Investor and Morgan Stanley Completed Acquisition of Molnlycke Health Care from Apax Partners | 84 | 1 |
| Deal Rationale | 84 | 1 |
| Company Overview | 85 | 1 |
| Global Medical Devices, Top Financial Advisors | 86 | 1 |
| Top Financial Advisors, PE/VC Deals Medical Devices | 86 | 1 |
| PE/VC Activity in Medical Devices- Appendix | 87 | 4 |
| Acronyms | 87 | 1 |
| Research Methodology | 88 | 2 |
| Secondary Research | 88 | 1 |
| Primary Research | 88 | 1 |
| Models | 89 | 1 |
| Forecasts | 89 | 1 |
| Expert Panels | 89 | 1 |
| Contact Us | 89 | 1 |
| Disclaimer | 90 | 1 |
| Sources | 90 | 1 |